Critically, ASMase overexpression attenuated the well-documented radioprotection elicited by the endothelial survival factor, basic fibroblast growth factor (bFGF), mimicking conditions expected in hypoxic tumor fractions. The gene discussed is SMPD1; the disease is neoplasm.